View article

Sechi GianPietro, Maria G. Deledda, Guido Bua, Wanda M. Satta, Giovanni A. Deiana, Giovanni M. Pes, and Giulio Rosati: Reduced intravenous glutathione in the treatment of early Parkinson’s Disease. Prog. Neuro-Psychopharmacol & Biol. Psychiat. 1996. 20, pp. 1159-1170

1. Several studies have demonstrated a deficiency in reduced glutathione (GSH) in the nigra of patients with Parkinson’s Disease (PD). In particular, the magnitude of reduction in GSH seems to parallel the severity of the disease. This finding may indicate a means by which the nigra cells could be therapeutically supported.